Want to take quizzes and track your credits?
The novel SARS-CoV-2 virus has caused more than 118 million cases of COVID-19 and more than 2.6 million deaths worldwide.1 To evaluate the use of potential therapeutic options—including dexamethasone, remdesivir, enoxaparin, heparin, colchicine, hydrocortisone, tocilizumab, azithromycin, hydroxychloroquine, and medication classes of angiotensin-2 converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)2—we measured daily and overall use percentages over the course of 2020 for hospitalized patients.
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: March 27, 2021.
Published: May 21, 2021. doi:10.1001/jamanetworkopen.2021.10775
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Watanabe JH et al. JAMA Network Open.
Corresponding Author: Jonathan H. Watanabe, PharmD, PhD, Associate Dean of Assessment and Quality, Professor of Clinical Pharmacy, Department of Clinical Pharmacy Practice, UC Irvine School of Pharmacy & Pharmaceutical Sciences, 101 Theory, Ste 100, Irvine, CA 92697 (email@example.com).
Author Contributions: Dr Watanabe had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Watanabe, Kwon, Nan, Abeles, Mehta.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Watanabe, Jia.
Critical revision of the manuscript for important intellectual content: Watanabe, Kwon, Nan, Abeles, Mehta.
Statistical analysis: Watanabe, Kwon, Nan, Jia.
Administrative, technical, or material support: Watanabe, Mehta.
Supervision: Watanabe, Nan, Mehta.
Conflict of Interest Disclosures: None reported.
You currently have no searches saved.
You currently have no courses saved.